Real-Time PCR (qPCR) Market Worth USD 8398 Million by 2027 at 8.92% CAGR - Report by Market Research Future (MRFR)

Real-Time PCR (qPCR) Market Growth and Insights by Product (Reagents & Consumables, Instruments, Software & Services), Application (Clinical, Research, and Forensics), End User (Hospitals &Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories) Competitive Market Dynamics, Size, Share and Forecast to 2027

New York, US, May 04, 2022 (GLOBE NEWSWIRE) -- Real-Time PCR (qPCR) Market Overview:

According to a Comprehensive Research Report by Market Research Future (MRFR), “Real-Time PCR Market Information by Product, Application, End User and Region – Forecast till 2027” the market is expected to cross USD 8,398.55 million in 2027 at a CAGR of 8.92% during the forecast period.

Market Scope:

The Real-Time PCR (qPCR) test is a qualitative detection of nucleic acid from a patient's specimen who is suffering from Coronavirus 2 severe acute respiratory syndrome (SARS CoV-2). The accumulation of amplification product is measured in real time as the reaction occurs, with product measurement after each cycle in real-time PCR. The introduction of a fluorescent reporter molecule in each reaction well allows for real-time detection of PCR products, which results in enhanced fluorescence as the amount of product DNA increases. DNA-binding dyes and fluorescently labeled sequence-specific primers or probes are among the fluorescence chemistries used for this purpose. The fluorescence signal is monitored as amplification occurs using specialized heat cyclers with fluorescence detecting modules. The overall amount of amplicon produced is proportional to the observed fluorescence; the amount of amplicon produced in each cycle is calculated using the change in fluorescence over time.

Competitive Landscape:

The major market players are

  • ABL SA Group(Luxembourg)

  • Agilent Technologies, Inc. (US)

  • Analytik Jena AG(Germany)

  • BD (US)

  • Bio-Rad Laboratories, Inc. (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Fluidigm Corporation(US)

  • Lumex Instruments(US)

  • Primerdesign Ltd(UK)

  • QIAGEN (Germany)

  • Takara Bio Inc. (Japan)

  • Thermo Fisher Scientific(US)

  • TOYOBO Inc. (Japan)

  • Vela Diagnostics (Singapore)

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/10672

Market USP:

Market Drivers

The COVID-19 pandemic sparked a surge in interest in real-time PCR (qPCR) for quick diagnosis. Pharmaceutical corporations are involved in research and development and collaborate with biotechnology firms. Furthermore, over the study period, advanced technologies in the real-time PCR (qPCR) procedure are expected to push real-time PCR (qPCR) market expansion. As a result of the growing demand for real-time PCR (qPCR) for the treatment of the current COVID-19 outbreak and technological improvements, healthcare providers may now identify the infection level in real-time. This is one of the most important elements driving the growth of the real-time PCR (qPCR) industry.